Nothing Special   »   [go: up one dir, main page]

Salomone et al., 2012 - Google Patents

A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape

Salomone et al., 2012

Document ID
6839560661852256410
Author
Salomone F
Cardarelli F
Di Luca M
Boccardi C
Nifosì R
Bardi G
Di Bari L
Serresi M
Beltram F
Publication year
Publication venue
Journal of controlled release

External Links

Snippet

Efficient endocytosis into a wide range of target cells and low toxicity make the arginine-rich Tat peptide (Tat11: YGRKKRRQRRR, residues 47–57 of HIV-1 Tat protein) an excellent transporter for delivery purposes. Unfortunately, molecules taken up by endocytosis undergo …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Similar Documents

Publication Publication Date Title
Salomone et al. A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape
Appelbaum et al. Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm
Vasconcelos et al. Therapeutic potential of cell-penetrating peptides
Fischer et al. A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides
Mueller et al. Comparison of cellular uptake using 22 CPPs in 4 different cell lines
Copolovici et al. Cell-penetrating peptides: design, synthesis, and applications
Verdurmen et al. Preferential uptake of L-versus D-amino acid cell-penetrating peptides in a cell type-dependent manner
US9303076B2 (en) Cell-penetrating peptides and uses thereof
Cerrato et al. Novel cell‐penetrating peptide targeting mitochondria
Di Pisa et al. Translocation mechanism (s) of cell-penetrating peptides: biophysical studies using artificial membrane bilayers
Bechara et al. Cell-penetrating peptides: 20 years later, where do we stand?
Foged et al. Cell-penetrating peptides for drug delivery across membrane barriers
Mandal et al. Cell‐penetrating homochiral cyclic peptides as nuclear‐targeting molecular transporters
Lin et al. Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting
Li et al. Multimerization of a proline-rich antimicrobial peptide, Chex-Arg20, alters its mechanism of interaction with the Escherichia coli membrane
Rokitskaya et al. Indolicidin action on membrane permeability: carrier mechanism versus pore formation
Ruczynski et al. Cell-penetrating peptides as a promising tool for delivery of various molecules into the cells
Zhang et al. Endocytosis and membrane potential are required for HeLa cell uptake of RI-CKTat9, a retro-inverso Tat cell penetrating peptide
Meng et al. CXC-mediated cellular uptake of miniproteins: forsaking “arginine magic”
Yamaguchi et al. Identification of cyclic peptides for facilitation of transcellular transport of phages across intestinal epithelium in vitro and in vivo
Fang et al. Tuning the antimicrobial pharmacophore to enable discovery of short lipopeptides with multiple modes of action
Li et al. Cationic amphiphilic polyproline helix P11LRR targets intracellular mitochondria
Ouyang et al. Improving the antimicrobial performance of amphiphilic cationic antimicrobial peptides using glutamic acid full-scan and positive charge compensation strategies
Buyanova et al. Discovery of a cyclic cell-penetrating peptide with improved endosomal escape and cytosolic delivery efficiency
Takada et al. Helix-stabilized cell-penetrating peptides for delivery of antisense morpholino oligomers: Relationships among helicity, cellular uptake, and antisense activity